According to new research, those who are taking the newest class of diabetic drugs in order to control blood sugar are more likely to become hospitalized with pancreatitis.

Scientists say that the glucagon-like peptide-1-based therapies (GLP-1) of the new drugs is the culprit for the increased risk of hospitalization for acute pancreatitis. Sitagliptin (brand named Janivia) and Extenatide (brand named Byetta) are suggested to contribute to the formation of lesions within the pancreas and the introductions of ducts in the organ. This causes an increased amount of inflammation.

Continue reading →

A trial was conducted by IRCM researchers (led by endocrinologist Dr. Rémi Rabasa-Lhoret) that compared a dual-hormone artificial pancreas with conventional diabetes treatments that use an insulin pump and showed improved glucose levels and lower risks of hypoglycemia.

The results showed that the artificial pancreas can have a huge impact where treatment is concerned for people who have been diagnosed with type 1 diabetes.

Continue reading →

Diabetes itself is growing. It has been for years now. What surprises many people however is to learn that type 1 diabetes among children is growing at a higher rate. In fact, in children aged under five years old, type 1 diabetes has increased by 70 percent in Philadelphia.

Information about diabetes has been collected since 1985 from the University of Pennsylvania.  Researchers led by nursing professor Terri H. Lipman, PhD, RN found that there was an increase in type 1 diabetes in children of 29 percent between the years of 1985 and 2004.

Continue reading →

Studies show that every 30 seconds someone around the world will lose their foot through amputation due to diabetic complications. According to a study by Sahlgrenska Academy in the University of Gathenburg, Sweden shows that just a few routine tips and techniques could cut down on the need for amputations by 50 percent.

These tips and techniques include regular check-ups from a doctor and wearing correct inserts and other necessary changes deemed warranted by a podiatrist.

Continue reading →

A little more than a century ago, diabetes was looked at as a fatal long-term illness. Today however, thanks to the discovery of insulin, it is looked at more as a chronic disease and due to many medical discoveries in medicine; there are many ways to make diabetes less of a struggle.

A team, which included researchers from Case Western Reserve University School of Medicine released information about their study and what they had discovered, which could lead to remarkable developments in patients who are trying to manage diabetes.

Continue reading →

An advisory panel of the Food and Drug Administration has recommended the approval of the use of canagliflozin, a new drug that is being developed by Johnson and Johnson, for the treatment of Type 2 diabetes.  This new medication — which will be called Invokana if it is eventually approved — is unique in that it lowers blood sugar levels by causing it to be excreted in the urine.  As well, patients might also experience weight loss when taking canagliflozin.

Continue reading →

According to a study performed by Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania and a team of researchers, the diabetes drug metformin works much differently than what researchers once understood it to work.

Studies performed on mice found that metformin represses the liver hormone glucagon’s capacity to produce a central signaling molecule.

Continue reading →

America’s society is dealing with the huge issue of obesity. Many people either don’t have time or do not feel like cooking at the end of the day and with hamburgers and fries so readily available, who really needs to?

Obesity is a growing problem due to overeating and it can develop from high insulin levels as well. Many researchers have suggested it the other way around, that obesity causes high insulin levels. This new theory is based on the testing of mice. It is very much the whole chicken or the egg problem, which one came first?

Continue reading →

Prescribed medication is popular all over the world but a major health concern in the United States is a problem referred to as “non-adherence”. This simply means that people are not taking the medication correctly that has been prescribed to them. When this happens, health issues like diabetes and chronic diseases become more of an issue.

A study that was led by researchers at the University of California, San Francisco, San Francisco General Hospital and Trauma Center and the Kaiser Permanente Division of Research has found a reason as to why medical non-adherence has become such an issue. The cause is ineffective communication.

Continue reading →

Research results were released that make a clearer understanding of the metabolic functions of obesity and its connection to Type 2 diabetes. Research studies are ongoing in regards to using this data about the protein mitoNEET in hopes of creating different medications for the treatment of diabetes.

The protein “mitoNEET” is a major part of the cell’s mitochondrion, which is the cell’s energy powerhouse. MitoNEET binds pioglitzaone (Actos TM) an insulin-sensitizing drug that is used in the treatment of Type 2 diabetes.

Continue reading →